speb/financial-data huggingface dataset:
BAC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 24656000000.00
BAC cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -70000000.00
BAC cash_flow (annual, 2023-12-31) — End Cash Position: 333073000000.00
BAC cash_flow (annual, 2023-12-31) — Financing Cash Flow: 93345000000.00
BAC cash_flow (annual, 2023-12-31) — Free Cash Flow: 44982000000.00
BAC cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 405000000.00
BAC income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 0.00
BAC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -17788000000.00
BAC income_statement (annual, 2023-12-31) — General And Administrative Expense: 44280000000.00
BAC balance_sheet (annual, 2023-12-31) — Goodwill: 69021000000.00
BAC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 69021000000.00
BAC balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 594555000000.00
BAC cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3405000000.00
BAC income_statement (annual, 2023-12-31) — Interest Expense: 73331000000.00
BAC income_statement (annual, 2023-12-31) — Interest Income: 130262000000.00
BAC cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 69604000000.00
BAC balance_sheet (annual, 2023-12-31) — Invested Capital: 597551000000.00
BAC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -35387000000.00
BAC balance_sheet (annual, 2023-12-31) — Investments And Advances: 1017946000000.00
BAC cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
BAC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 65396000000.00
BAC balance_sheet (annual, 2023-12-31) — Long Term Debt: 302204000000.00
BAC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 302204000000.00
BAC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 65396000000.00
BAC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -44571000000.00
BAC balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1209000000.00
BAC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -4576000000.00
BAC income_statement (annual, 2023-12-31) — Net Income: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 24656000000.00
BAC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 26305000000.00
BAC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Net Interest Income: 56931000000.00
BAC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -4238000000.00
BAC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 25987000000.00
BAC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 20825000000.00
BAC cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -717000000.00
BAC cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -5258000000.00
BAC balance_sheet (annual, 2023-12-31) — Net PPE: 11855000000.00
BAC cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
BAC cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 5162000000.00
BAC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 222625000000.00
BAC income_statement (annual, 2023-12-31) — Normalized Income: 26305000000.00
BAC income_statement (annual, 2023-12-31) — Occupancy And Equipment: 7164000000.00
BAC cash_flow (annual, 2023-12-31) — Operating Cash Flow: 44982000000.00
BAC cash_flow (annual, 2023-12-31) — Operating Gains Losses: 405000000.00
BAC income_statement (annual, 2023-12-31) — Operating Revenue: 102769000000.00
BAC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 7895457665.00
BAC balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 32098000000.00
BAC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -17788000000.00
BAC income_statement (annual, 2023-12-31) — Other Gand A: 5950000000.00
BAC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 7708000000.00
BAC income_statement (annual, 2023-12-31) — Other Non Interest Expense: 6707000000.00
BAC balance_sheet (annual, 2023-12-31) — Other Receivables: 14816000000.00
BAC balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 266649000000.00
BAC income_statement (annual, 2023-12-31) — Other Special Charges: 2100000000.00
BAC balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 409797858.00
BAC balance_sheet (annual, 2023-12-31) — Preferred Stock: 28397000000.00
BAC income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 1649000000.00
BAC balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 28397000000.00
BAC cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
BAC cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
BAC income_statement (annual, 2023-12-31) — Pretax Income: 32530000000.00
BAC income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 2159000000.00
BAC cash_flow (annual, 2023-12-31) — Purchase Of Investment: -291057000000.00
BAC balance_sheet (annual, 2023-12-31) — Receivables: 96697000000.00
BAC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2057000000.00
BAC cash_flow (annual, 2023-12-31) — Repayment Of Debt: -44571000000.00
BAC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -4576000000.00
BAC balance_sheet (annual, 2023-12-31) — Retained Earnings: 224672000000.00
BAC income_statement (annual, 2023-12-31) — Salaries And Wages: 38330000000.00
BAC cash_flow (annual, 2023-12-31) — Sale Of Investment: 286819000000.00
BAC income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 5535000000.00
BAC income_statement (annual, 2023-12-31) — Selling General And Administration: 49815000000.00
BAC balance_sheet (annual, 2023-12-31) — Share Issued: 7895457665.00
BAC income_statement (annual, 2023-12-31) — Special Income Charges: -2100000000.00
BAC cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2942000000.00
BAC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 291646000000.00
BAC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 194228000000.00
BAC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (annual, 2023-12-31) — Tax Provision: 6225000000.00
BAC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.06
BAC balance_sheet (annual, 2023-12-31) — Total Assets: 3180151000000.00
BAC balance_sheet (annual, 2023-12-31) — Total Capitalization: 593850000000.00
BAC balance_sheet (annual, 2023-12-31) — Total Debt: 334302000000.00
BAC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 291646000000.00
BAC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2888505000000.00
BAC income_statement (annual, 2023-12-31) — Total Unusual Items: -2100000000.00
BAC income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2100000000.00
BAC balance_sheet (annual, 2023-12-31) — Trading Securities: 146539000000.00
BAC income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
BAC income_statement (annual, 2024-12-31) — +Total Revenue: 105856000000.00
BAC balance_sheet (annual, 2024-12-31) — Accounts Receivable: 82247000000.00
BAC balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 12175000000.00
BAC income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
BAC income_statement (annual, 2024-12-31) — Basic Average Shares: 7855500000.00
BAC income_statement (annual, 2024-12-31) — Basic EPS: 3.25
BAC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 333073000000.00
BAC balance_sheet (annual, 2024-12-31) — Capital Stock: 68495000000.00
BAC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 296486000000.00
BAC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 571195000000.00
BAC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -9503000000.00
BAC balance_sheet (annual, 2024-12-31) — Cash Financial: 26003000000.00
BAC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 60369000000.00
BAC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -90693000000.00
BAC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -8805000000.00
BAC cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1025000000.00
BAC cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -4515000000.00
BAC cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -45504000000.00
BAC cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1025000000.00
BAC cash_flow (annual, 2024-12-31) — Change In Working Capital: -53315000000.00
BAC cash_flow (annual, 2024-12-31) — Changes In Cash: -39129000000.00
BAC balance_sheet (annual, 2024-12-31) — Common Stock: 45336000000.00
BAC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 270804000000.00
BAC cash_flow (annual, 2024-12-31) — Common Stock Payments: -13104000000.00
BAC balance_sheet (annual, 2024-12-31) — Current Debt: 43391000000.00
BAC balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 43391000000.00
BAC cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1127000000.00
BAC cash_flow (annual, 2024-12-31) — Deferred Tax: -1127000000.00
BAC cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2189000000.00
BAC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2189000000.00
BAC balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 39353000000.00
BAC income_statement (annual, 2024-12-31) — Diluted Average Shares: 7935800000.00
BAC income_statement (annual, 2024-12-31) — Diluted EPS: 3.21
BAC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 25344000000.00
BAC cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -3830000000.00
BAC cash_flow (annual, 2024-12-31) — End Cash Position: 290114000000.00
BAC cash_flow (annual, 2024-12-31) — Financing Cash Flow: 60369000000.00
BAC cash_flow (annual, 2024-12-31) — Free Cash Flow: -8805000000.00
BAC cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 29000000.00
BAC income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 0.00
BAC balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -15285000000.00
BAC income_statement (annual, 2024-12-31) — General And Administrative Expense: 44173000000.00
BAC balance_sheet (annual, 2024-12-31) — Goodwill: 69021000000.00
BAC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 69021000000.00
BAC balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 558677000000.00
BAC cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3822000000.00
BAC income_statement (annual, 2024-12-31) — Interest Expense: 90547000000.00
BAC income_statement (annual, 2024-12-31) — Interest Income: 146607000000.00
BAC cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 89687000000.00
BAC balance_sheet (annual, 2024-12-31) — Invested Capital: 597474000000.00
BAC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -90693000000.00
BAC balance_sheet (annual, 2024-12-31) — Investments And Advances: 1061416000000.00
BAC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
BAC cash_flow (annual, 2024-12-31) — Issuance Of Debt: 56683000000.00
BAC balance_sheet (annual, 2024-12-31) — Long Term Debt: 283279000000.00
BAC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 283279000000.00
BAC cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 56683000000.00
BAC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -70411000000.00
BAC balance_sheet (annual, 2024-12-31) — Long Term Provisions: 1096000000.00
BAC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -13104000000.00
BAC balance_sheet (annual, 2024-12-31) — Net Debt: 30184000000.00
BAC income_statement (annual, 2024-12-31) — Net Income: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 25344000000.00
BAC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 26973000000.00
BAC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Net Interest Income: 56060000000.00
BAC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -48456000000.00
BAC cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1154000000.00
BAC cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -13728000000.00
BAC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -127000000.00
BAC cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -4145000000.00
BAC balance_sheet (annual, 2024-12-31) — Net PPE: 12168000000.00
BAC cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: -5254000000.00
BAC cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 12574000000.00
BAC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 224942000000.00
BAC income_statement (annual, 2024-12-31) — Normalized Income: 26973000000.00
BAC income_statement (annual, 2024-12-31) — Occupancy And Equipment: 7289000000.00
BAC cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8805000000.00
BAC cash_flow (annual, 2024-12-31) — Operating Gains Losses: 29000000.00
BAC income_statement (annual, 2024-12-31) — Operating Revenue: 105856000000.00
BAC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 7610862311.00
BAC balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 43391000000.00
BAC balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -15285000000.00
BAC income_statement (annual, 2024-12-31) — Other Gand A: 3991000000.00
BAC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 7522000000.00
BAC income_statement (annual, 2024-12-31) — Other Non Interest Expense: 7231000000.00
BAC balance_sheet (annual, 2024-12-31) — Other Receivables: 15672000000.00
BAC balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 346432000000.00
BAC balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 409797847.00
BAC balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 409797847.00
BAC balance_sheet (annual, 2024-12-31) — Preferred Stock: 23159000000.00
BAC income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 1629000000.00
BAC balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 23159000000.00
BAC cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
BAC cash_flow (annual, 2024-12-31) — Preferred Stock Payments: -5254000000.00
BAC income_statement (annual, 2024-12-31) — Pretax Income: 33223000000.00
BAC income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2669000000.00
BAC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -390911000000.00
BAC balance_sheet (annual, 2024-12-31) — Receivables: 97919000000.00
BAC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2189000000.00
BAC cash_flow (annual, 2024-12-31) — Repayment Of Debt: -70411000000.00
BAC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -18358000000.00
BAC balance_sheet (annual, 2024-12-31) — Retained Earnings: 240753000000.00
BAC income_statement (annual, 2024-12-31) — Salaries And Wages: 40182000000.00
BAC cash_flow (annual, 2024-12-31) — Sale Of Investment: 342455000000.00
BAC income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 5450000000.00
BAC income_statement (annual, 2024-12-31) — Selling General And Administration: 49623000000.00
BAC balance_sheet (annual, 2024-12-31) — Share Issued: 7610862311.00
BAC cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3433000000.00
BAC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 293963000000.00
BAC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 201783000000.00
BAC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (annual, 2024-12-31) — Tax Provision: 6250000000.00
BAC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.19
BAC balance_sheet (annual, 2024-12-31) — Total Assets: 3261299000000.00
BAC balance_sheet (annual, 2024-12-31) — Total Capitalization: 577242000000.00
BAC balance_sheet (annual, 2024-12-31) — Total Debt: 326670000000.00
BAC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 293963000000.00
BAC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2967336000000.00
BAC balance_sheet (annual, 2024-12-31) — Trading Securities: 144132000000.00
BAC income_statement (quarterly, 2025-03-31) — +Total Revenue: 28247000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 80329000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 12310000000.00
BAC income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
BAC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7677900000.00
BAC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.91
BAC cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 290114000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Capital Stock: 61537000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 280861000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 609226000000.00
BAC cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2552000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Cash Financial: 24734000000.00
BAC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 72832000000.00
BAC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -89010000000.00
BAC cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2184000000.00
BAC cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -8308000000.00
BAC cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 4198000000.00
BAC cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -10970000000.00
BAC cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -8308000000.00
BAC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -12481000000.00
BAC cash_flow (quarterly, 2025-03-31) — Changes In Cash: -18362000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Common Stock: 41038000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 275082000000.00
BAC cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4521000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Current Debt: 41470000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 41470000000.00
BAC cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -40000000.00
BAC cash_flow (quarterly, 2025-03-31) — Deferred Tax: -40000000.00
BAC cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 565000000.00
BAC cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 565000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 35365000000.00
BAC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7770800000.00
BAC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.90
BAC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 6954000000.00
BAC cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1827000000.00
BAC cash_flow (quarterly, 2025-03-31) — End Cash Position: 273579000000.00
BAC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 72832000000.00
BAC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2184000000.00
BAC cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 2000000.00
BAC income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 0.00
BAC balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -13271000000.00
BAC income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11948000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Goodwill: 69021000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 69021000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 550720000000.00
BAC income_statement (quarterly, 2025-03-31) — Interest Expense: 19623000000.00
BAC income_statement (quarterly, 2025-03-31) — Interest Income: 34066000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 620698000000.00
BAC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -89010000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1107638000000.00
BAC cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 33640000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 304146000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 304146000000.00
BAC cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 33640000000.00
BAC cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -16333000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1110000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -4521000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Net Debt: 64755000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6954000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7360000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Net Interest Income: 14443000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -17298000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 15386000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 17307000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1221000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -799000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Net PPE: 12151000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: -2669000000.00
BAC cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -1921000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 226560000000.00
BAC income_statement (quarterly, 2025-03-31) — Normalized Income: 7360000000.00
BAC income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 1856000000.00
BAC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2184000000.00
BAC cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2000000.00
BAC income_statement (quarterly, 2025-03-31) — Operating Revenue: 28247000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7560084716.00
BAC balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 41470000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -13271000000.00
BAC income_statement (quarterly, 2025-03-31) — Other Gand A: 1059000000.00
BAC cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 16000000.00
BAC income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 1894000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Other Receivables: 15657000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 376249000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 20499000000.00
BAC income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 406000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 20499000000.00
BAC cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: -2669000000.00
BAC income_statement (quarterly, 2025-03-31) — Pretax Income: 8997000000.00
BAC income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 652000000.00
BAC cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -72075000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Receivables: 95986000000.00
BAC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 565000000.00
BAC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -16333000000.00
BAC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -7190000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 247315000000.00
BAC income_statement (quarterly, 2025-03-31) — Salaries And Wages: 10889000000.00
BAC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 54777000000.00
BAC income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1420000000.00
BAC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 13368000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Share Issued: 7560084716.00
BAC cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 999000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 295581000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 206061000000.00
BAC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (quarterly, 2025-03-31) — Tax Provision: 1637000000.00
BAC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
BAC balance_sheet (quarterly, 2025-03-31) — Total Assets: 3349424000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 599727000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Total Debt: 345616000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 295581000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3053843000000.00
BAC balance_sheet (quarterly, 2025-03-31) — Trading Securities: 168359000000.00
BAC income_statement (quarterly, 2025-06-30) — +Total Revenue: 26463000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 93964000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 10897000000.00
BAC income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7581200000.00
BAC income_statement (quarterly, 2025-06-30) — Basic EPS: 0.90
BAC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 273579000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 59923000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 275388000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 627780000000.00
BAC cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2200000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Cash Financial: 26661000000.00
BAC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 55059000000.00
BAC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -56918000000.00
BAC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -9132000000.00
BAC cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 17889000000.00
BAC cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -23418000000.00
BAC cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -14879000000.00
BAC cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 17889000000.00
BAC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -18927000000.00
BAC cash_flow (quarterly, 2025-06-30) — Changes In Cash: -10991000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Common Stock: 36428000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 276104000000.00
BAC cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -5302000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Current Debt: 47891000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 47891000000.00
BAC cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -220000000.00
BAC cash_flow (quarterly, 2025-06-30) — Deferred Tax: -220000000.00
BAC cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 571000000.00
BAC cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 571000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 41693000000.00
BAC income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7651600000.00
BAC income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.89
BAC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 6825000000.00
BAC cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 3423000000.00
BAC cash_flow (quarterly, 2025-06-30) — End Cash Position: 266011000000.00
BAC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 55059000000.00
BAC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -9132000000.00
BAC cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 18000000.00
BAC income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 0.00
BAC balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -12504000000.00
BAC income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11351000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Goodwill: 69021000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 69021000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 541286000000.00
BAC income_statement (quarterly, 2025-06-30) — Interest Expense: 20203000000.00
BAC income_statement (quarterly, 2025-06-30) — Interest Income: 34873000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 637413000000.00
BAC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -56918000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1106468000000.00
BAC cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 23286000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 313418000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 313418000000.00
BAC cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 23286000000.00
BAC cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -19631000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 1143000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -5302000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Net Debt: 85921000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income: 7116000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 6825000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7116000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7116000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7116000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7152000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7116000000.00
BAC income_statement (quarterly, 2025-06-30) — Net Interest Income: 14670000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 12478000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 10076000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 3655000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 63000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1463000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Net PPE: 12254000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 2996000000.00
BAC cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 6421000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 230578000000.00
BAC income_statement (quarterly, 2025-06-30) — Normalized Income: 7116000000.00
BAC income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 1836000000.00
BAC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -9132000000.00
BAC cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 18000000.00
BAC income_statement (quarterly, 2025-06-30) — Operating Revenue: 26463000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 7436679485.00
BAC balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 47891000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -12504000000.00
BAC income_statement (quarterly, 2025-06-30) — Other Gand A: 1019000000.00
BAC cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -272000000.00
BAC income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 1819000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Other Receivables: 15710000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 378033000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 23495000000.00
BAC income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 291000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 23495000000.00
BAC cash_flow (quarterly, 2025-06-30) — Preferred Stock Payments: 0.00
BAC income_statement (quarterly, 2025-06-30) — Pretax Income: 7688000000.00
BAC income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 640000000.00
BAC cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -51563000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Receivables: 109674000000.00
BAC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 571000000.00
BAC cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -19631000000.00
BAC cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -5302000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 252180000000.00
BAC income_statement (quarterly, 2025-06-30) — Salaries And Wages: 10332000000.00
BAC cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 64041000000.00
BAC income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1537000000.00
BAC income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12888000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Share Issued: 7436679485.00
BAC cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1015000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 299599000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 207083000000.00
BAC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (quarterly, 2025-06-30) — Tax Provision: 572000000.00
BAC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.07
BAC balance_sheet (quarterly, 2025-06-30) — Total Assets: 3441142000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 613017000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Total Debt: 361309000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 299599000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3141543000000.00
BAC balance_sheet (quarterly, 2025-06-30) — Trading Securities: 176252000000.00
BAC income_statement (quarterly, 2025-09-30) — +Total Revenue: 28088000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 99863000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 14343000000.00
BAC income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 56000000.00
BAC income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7466000000.00
BAC income_statement (quarterly, 2025-09-30) — Basic EPS: 1.08
BAC cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 266011000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Capital Stock: 57756000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 254719000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 580519000000.00
BAC cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2451000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Cash Financial: 25352000000.00
BAC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -67990000000.00
BAC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 1943000000.00
BAC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 46874000000.00
BAC cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 10658000000.00
BAC cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5323000000.00
BAC cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 30536000000.00
BAC cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 10658000000.00
BAC cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 34463000000.00
BAC cash_flow (quarterly, 2025-09-30) — Changes In Cash: -19173000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Common Stock: 31764000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 278160000000.00
BAC cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -5300000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Current Debt: 54200000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 54200000000.00
BAC cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 5000000.00
BAC cash_flow (quarterly, 2025-09-30) — Deferred Tax: 5000000.00
BAC cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 584000000.00
BAC cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 584000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 40157000000.00
BAC income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7627100000.00
BAC income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.06
BAC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 8096000000.00
BAC cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -331000000.00
BAC cash_flow (quarterly, 2025-09-30) — End Cash Position: 246507000000.00
BAC cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -67990000000.00
BAC cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 46874000000.00
BAC cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 3000000.00
BAC income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 0.00
BAC balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -11745000000.00
BAC income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 11435000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Goodwill: 69021000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 69021000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 531414000000.00
BAC income_statement (quarterly, 2025-09-30) — Interest Expense: 20133000000.00
BAC income_statement (quarterly, 2025-09-30) — Interest Income: 35366000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 643844000000.00
BAC cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 1943000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1096833000000.00
BAC cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 2497000000.00
BAC cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 18929000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 311484000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 311484000000.00
BAC cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 18929000000.00
BAC cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -21929000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 1109000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -5300000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Net Debt: 110965000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 8040000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 8469000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Net Interest Income: 15233000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4990000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 3302000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -3000000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 239000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -554000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Net PPE: 12348000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 2497000000.00
BAC cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 6302000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 235131000000.00
BAC income_statement (quarterly, 2025-09-30) — Normalized Income: 8469000000.00
BAC income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 1872000000.00
BAC cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 46874000000.00
BAC cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 3000000.00
BAC income_statement (quarterly, 2025-09-30) — Operating Revenue: 28088000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7329421929.00
BAC balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 54200000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -11745000000.00
BAC income_statement (quarterly, 2025-09-30) — Other Gand A: 912000000.00
BAC cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1555000000.00
BAC income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 1827000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Other Receivables: 16236000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 390293000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 25992000000.00
BAC income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 429000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 25992000000.00
BAC cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 2497000000.00
BAC cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
BAC income_statement (quarterly, 2025-09-30) — Pretax Income: 9456000000.00
BAC income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 606000000.00
BAC cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -73066000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Receivables: 116099000000.00
BAC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 584000000.00
BAC cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -21929000000.00
BAC cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -5300000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 258141000000.00
BAC income_statement (quarterly, 2025-09-30) — Salaries And Wages: 10523000000.00
BAC cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 68076000000.00
BAC income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1597000000.00
BAC income_statement (quarterly, 2025-09-30) — Selling General And Administration: 13032000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Share Issued: 7329421929.00
BAC cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1018000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 304152000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 209139000000.00
BAC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (quarterly, 2025-09-30) — Tax Provision: 987000000.00
BAC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.10
BAC balance_sheet (quarterly, 2025-09-30) — Total Assets: 3403716000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 615636000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Total Debt: 365684000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 304152000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3099564000000.00
BAC balance_sheet (quarterly, 2025-09-30) — Trading Securities: 160783000000.00
BAC income_statement (annual, 2025-12-31) — +Total Revenue: 113097000000.00
BAC income_statement (quarterly, 2025-12-31) — +Total Revenue: 31180000000.00
BAC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 98186000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 98186000000.00
BAC balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 16177000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 16177000000.00
BAC income_statement (annual, 2025-12-31) — Average Dilution Earnings: 223000000.00
BAC income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 56000000.00
BAC income_statement (annual, 2025-12-31) — Basic Average Shares: 7521900000.00
BAC income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7364900000.00
BAC income_statement (annual, 2025-12-31) — Basic EPS: 3.86
BAC income_statement (quarterly, 2025-12-31) — Basic EPS: 0.99
BAC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 290114000000.00
BAC cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 246507000000.00
BAC balance_sheet (annual, 2025-12-31) — Capital Stock: 52076000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 52076000000.00
BAC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 239319000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 239319000000.00
BAC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 555897000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 555897000000.00
BAC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -9563000000.00
BAC cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2360000000.00
BAC balance_sheet (annual, 2025-12-31) — Cash Financial: 28595000000.00
BAC balance_sheet (quarterly, 2025-12-31) — Cash Financial: 28595000000.00
BAC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 69948000000.00